Repigmentation through Melanocyte Regeneration in Vitiligo.

Repigmentation in vitiligo is the process that replaces, in the epidermal basal layer of vitiligo skin, the mature melanocytes that have been killed by cytotoxic T cells specific for melanocyte antigens. It consists of mobilization of melanocyte precursors in the hair follicle bulge and infundibulum to proliferate, migrate, and differentiate into mature melanocytes, moving from the hair follicle bulge to the interfollicular epidermis. The most common clinical presentation of repigmentation in vitiligo is the perifollicular pattern. The most potent stimulus for repigmentation is the UV light.

[1]  S. Chang,et al.  FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes , 2016, Pigment cell & melanoma research.

[2]  H. Nakauchi,et al.  A melanocyte–melanoma precursor niche in sweat glands of volar skin , 2014, Pigment cell & melanoma research.

[3]  G. Costin,et al.  New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo , 2009, Medicinal research reviews.

[4]  S. Nishikawa,et al.  Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.

[5]  D. Parsad.  Natural History and Prognosis , 2010 .

[6]  M. García-Carrasco,et al.  Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study , 2013, Clinical and experimental immunology.

[7]  D. Parsad,et al.  Understanding the Mechanisms of Repigmentation in Vitiligo , 2007 .

[8]  S. Im,et al.  The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients. , 1993, Journal of dermatological science.

[9]  Yiwei Zhao,et al.  Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. , 2011, The Journal of investigative dermatology.

[10]  D. Ashcroft,et al.  Interventions for vitiligo. , 2006, The Cochrane database of systematic reviews.

[11]  J Cui,et al.  Role of hair follicles in the repigmentation of vitiligo. , 1991, The Journal of investigative dermatology.

[12]  R. Paus,et al.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles , 2008, The British journal of dermatology.

[13]  R. Falabella.  VITILIGO AND THE MELANOCYTE RESERVOIR , 2009, Indian journal of dermatology.

[14]  A. Jimeno,et al.  Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. , 2013, The Journal of clinical investigation.

[15]  J. A. Burch,et al.  KIT expression reveals a population of precursor melanocytes in human skin. , 1996, The Journal of investigative dermatology.

[16]  P M Bossuyt,et al.  Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. , 1998, Archives of dermatology.

[17]  D. Roop,et al.  Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors. , 2015, The Journal of investigative dermatology.

[18]  K. Wolff,et al.  Fitzpatrick's Dermatology in General Medicine. 7th Edition , 2008 .

[19]  S. Nakata,et al.  Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. , 2013, The Journal of investigative dermatology.

[20]  Qiang Li,et al.  Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta‐analysis , 2016, Dermatologic therapy.

[21]  M. Osawa.  Melanocyte stem cells , 2009 .

[22]  Kimberly Johnson,et al.  Extrafollicular Dermal Melanocyte Stem Cells and Melanoma , 2012, Stem cells international.

[23]  M. Lebwohl,et al.  Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. , 2015, JAMA dermatology.

[24]  W. Coleman,et al.  Fitzpatrickʼs Dermatology in General Medicine , 2008 .

[25]  C. Scaletta,et al.  Sunlight and carcinogenesis: Expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations , 1998, International journal of cancer.

[26]  J. Pasricha,et al.  Demonstration of tyrosinase in the vitiligo skin of human beings by a sensitive fluorometric method as well as by 14C(U)-L-tyrosine incorporation into melanin. , 1982, The Journal of investigative dermatology.

[27]  D. Torchia,et al.  Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters , 2011, Cutaneous and ocular toxicology.

[28]  S. Nishikawa,et al.  Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. , 1998, Development.

[29]  E. Carrascal,et al.  MELANOCYTE RESERVOIR IN VITILIGO , 1994, International journal of dermatology.

[30]  T. Hirobe.  How are proliferation and differentiation of melanocytes regulated? , 2011, Pigment cell & melanoma research.

[31]  P. Poirier,et al.  Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo , 2004, Lipids in Health and Disease.

[32]  S. Dogra,et al.  Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. , 2004, Journal of the American Academy of Dermatology.

[33]  K. Alghamdi,et al.  Treatment of generalized vitiligo with anti-TNF-α Agents. , 2012, Journal of drugs in dermatology : JDD.

[34]  Sung Bin Cho,et al.  Various Patterns of Repigmentation after Narrowband UVB Monotherapy in Patients with Vitiligo , 2005, The Journal of dermatology.

[35]  R. Staricco,et al.  Activation of the amelanotic melanocytes in the outer root sheath of the hair follicle following ultra violet rays exposure. , 1962, The Journal of investigative dermatology.

[36]  C. Hunter,et al.  Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo , 2014, The Journal of investigative dermatology.

[37]  M. Nishimura,et al.  Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo , 2013, Science Translational Medicine.

[38]  B. King,et al.  Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. , 2015, JAMA dermatology.

[39]  L. Davids,et al.  A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem‐cell reservoir of melanocytes? , 2009, Clinical and experimental dermatology.

[40]  Glenville Jones.  Vitamin D analogs. , 2001, Endocrinology and metabolism clinics of North America.

[41]  George F. Cohen,et al.  Rapid response of facial vitiligo to 308nm excimer laser and topical calcipotriene. , 2011, ˜The œJournal of clinical and aesthetic dermatology.

[42]  Piul S. Rabbani,et al.  Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling , 2013, Nature Medicine.

[43]  T. Horikawa,et al.  DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. , 1996, The Journal of investigative dermatology.

[44]  A. Lin,et al.  Efficacy of topical calcineurin inhibitors in vitiligo , 2013, International journal of dermatology.

[45]  H. Y. Kang,et al.  FK506 increases pigmentation and migration of human melanocytes , 2006, The British journal of dermatology.

[46]  Yun-Seok Yang,et al.  Clinical study of repigmentation patterns with either narrow‐band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients , 2010, International journal of dermatology.

[47]  A. Christiano,et al.  Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). , 2016, Journal of the American Academy of Dermatology.

[48]  G. Costin,et al.  Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. , 2008, Current drug targets.

[49]  A. Hachiya,et al.  The Essential Role of p53 in Hyperpigmentation of the Skin via Regulation of Paracrine Melanogenic Cytokine Receptor Signaling* , 2009, Journal of Biological Chemistry.

[50]  D. Tobin,et al.  Melanocytes are not absent in lesional skin of long duration vitiligo. , 2000, The Journal of pathology.

[51]  S. Nishikawa,et al.  Review: melanocyte migration and survival controlled by SCF/c-kit expression. , 2001, The journal of investigative dermatology. Symposium proceedings.

[52]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .

[53]  W. Hsu,et al.  Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis , 2012, The Journal of investigative dermatology.

[54]  S. Stevenson,et al.  Effect of estrogens on skin aging and the potential role of SERMs , 2007, Clinical interventions in aging.

[55]  M. Ludovici,et al.  Vitiligo: A Possible Model of Degenerative Diseases , 2013, PloS one.

[56]  G. Sisti,et al.  Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review* , 2016, Anais brasileiros de dermatologia.

[57]  S. Chang,et al.  Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? , 2015, Annals of dermatology.

[58]  Y. Kawaguchi,et al.  Kit(+) melanocytes seem to contribute to melanocyte proliferation after UV exposure as precursor cells. , 2001, The Journal of investigative dermatology.

[59]  M. Ziman,et al.  PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas) , 2010, PloS one.

[60]  A. Christiano,et al.  Pharmacologic inhibition of JAK-STAT signaling promotes hair growth , 2015, Science Advances.

[61]  E. Morrisey,et al.  Distinct functions for Wnt/β-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis. , 2013, Cell stem cell.

[62]  P. Sun,et al.  Pygo2 regulates β-catenin–induced activation of hair follicle stem/progenitor cells and skin hyperplasia , 2014, Proceedings of the National Academy of Sciences.

[63]  C. Lan,et al.  FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo , 2005, The British journal of dermatology.

[64]  R. Ballotti,et al.  Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients. , 2015, The Journal of investigative dermatology.

[65]  R. Staricco.  AMELANOTIC MELANOCYTES IN THE OUTER SHEATH OF THE HUMAN HAIR FOLLICLE AND THEIR ROLE IN THE REPIGMENTATION OF REGENERATED EPIDERMIS * , 1963, Annals of the New York Academy of Sciences.

[66]  K. Will,et al.  P53-Dependent UVB Responsiveness of Human Keratinocytes Can Be Altered by Cultivation on Cell Cycle-arrested Dermal Fibroblasts , 2000, Photochemistry and photobiology.

[67]  V. Hearing,et al.  Human skin pigmentation: melanocytes modulate skin color in response to stress , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  S. Dogra,et al.  Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. , 2005, Dermatology online journal.

[69]  D. I. Smith,et al.  Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab. , 2008, Journal of the American Academy of Dermatology.

[70]  J. Harris,et al.  Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo. , 2015, Annals of translational medicine.

[71]  D. Tobin,et al.  Isolation and long-term culture of human hair-follicle melanocytes. , 1995, The Journal of investigative dermatology.

[72]  M. Picardo,et al.  Vitiligo: characterization of melanocytes in repigmented skin after punch grafting , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[73]  M. Cario-André,et al.  Clinical repigmentation patterns in paediatric vitiligo , 2016, The British journal of dermatology.

[74]  R. Spritz.  Modern vitiligo genetics sheds new light on an ancient disease , 2013, The Journal of dermatology.

[75]  A. Batalla,et al.  Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence? , 2011, Case Reports in Dermatology.

[76]  B. Kumar,et al.  Psoralen–ultraviolet A vs. narrow‐band ultraviolet B phototherapy for the treatment of vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[77]  J. Ortonne,et al.  PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. , 1980, The Journal of investigative dermatology.

[78]  S. Gregoriou,et al.  Etanercept in the Treatment of Vitiligo , 2007, Dermatology.

[79]  Eun-So Lee,et al.  Changes of Epidermal Thickness in Vitiligo , 2015, The American Journal of dermatopathology.

[80]  M. Leandro,et al.  Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab , 2013, Dermatologic therapy.

[81]  D. Fisher,et al.  Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche , 2005, Science.